Cargando…

Stratification of coronary artery disease patients for revascularization procedure based on estimating adverse effects

BACKGROUND: Percutaneous coronary intervention (PCI) is the most commonly performed treatment for coronary atherosclerosis. It is associated with a higher incidence of repeat revascularization procedures compared to coronary artery bypass grafting surgery. Recent results indicate that PCI is only co...

Descripción completa

Detalles Bibliográficos
Autores principales: Pölsterl, Sebastian, Singh, Maneesh, Katouzian, Amin, Navab, Nassir, Kastrati, Adnan, Ladic, Lance, Kamen, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336731/
https://www.ncbi.nlm.nih.gov/pubmed/25889930
http://dx.doi.org/10.1186/s12911-015-0131-0
_version_ 1782358509339279360
author Pölsterl, Sebastian
Singh, Maneesh
Katouzian, Amin
Navab, Nassir
Kastrati, Adnan
Ladic, Lance
Kamen, Ali
author_facet Pölsterl, Sebastian
Singh, Maneesh
Katouzian, Amin
Navab, Nassir
Kastrati, Adnan
Ladic, Lance
Kamen, Ali
author_sort Pölsterl, Sebastian
collection PubMed
description BACKGROUND: Percutaneous coronary intervention (PCI) is the most commonly performed treatment for coronary atherosclerosis. It is associated with a higher incidence of repeat revascularization procedures compared to coronary artery bypass grafting surgery. Recent results indicate that PCI is only cost-effective for a subset of patients. Estimating risks of treatment options would be an effort toward personalized treatment strategy for coronary atherosclerosis. METHODS: In this paper, we propose to model clinical knowledge about the treatment of coronary atherosclerosis to identify patient-subgroup-specific classifiers to predict the risk of adverse events of different treatment options. We constructed one model for each patient subgroup to account for subgroup-specific interpretation and availability of features and hierarchically aggregated these models to cover the entire data. In addition, we deviated from the current clinical workflow only for patients with high probability of benefiting from an alternative treatment, as suggested by this model. Consequently, we devised a two-stage test with optimized negative and positive predictive values as the main indicators of performance. Our analysis was based on 2,377 patients that underwent PCI. Performance was compared with a conventional classification model and the existing clinical practice by estimating effectiveness, safety, and costs for different endpoints (6 month angiographic restenosis, 12 and 36 month hazardous events). RESULTS: Compared to the current clinical practice, the proposed method achieved an estimated reduction in adverse effects by 25.0% (95% CI, 17.8 to 30.2) for hazardous events at 36 months and 31.2% (95% CI, 25.4 to 39.0) for hazardous events at 12 months. Estimated total savings per patient amounted to $693 and $794 at 12 and 36 months, respectively. The proposed subgroup-specific method outperformed conventional population wide regression: The median area under the receiver operating characteristic curve increased from 0.57 to 0.61 for prediction of angiographic restenosis and from 0.76 to 0.85 for prediction of hazardous events. CONCLUSIONS: The results of this study demonstrated the efficacy of deployment of bare-metal stents and coronary artery bypass grafting surgery for subsets of patients. This is one effort towards development of personalized treatment strategies for patients with coronary atherosclerosis that could significantly impact associated treatment costs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12911-015-0131-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4336731
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43367312015-02-23 Stratification of coronary artery disease patients for revascularization procedure based on estimating adverse effects Pölsterl, Sebastian Singh, Maneesh Katouzian, Amin Navab, Nassir Kastrati, Adnan Ladic, Lance Kamen, Ali BMC Med Inform Decis Mak Research Article BACKGROUND: Percutaneous coronary intervention (PCI) is the most commonly performed treatment for coronary atherosclerosis. It is associated with a higher incidence of repeat revascularization procedures compared to coronary artery bypass grafting surgery. Recent results indicate that PCI is only cost-effective for a subset of patients. Estimating risks of treatment options would be an effort toward personalized treatment strategy for coronary atherosclerosis. METHODS: In this paper, we propose to model clinical knowledge about the treatment of coronary atherosclerosis to identify patient-subgroup-specific classifiers to predict the risk of adverse events of different treatment options. We constructed one model for each patient subgroup to account for subgroup-specific interpretation and availability of features and hierarchically aggregated these models to cover the entire data. In addition, we deviated from the current clinical workflow only for patients with high probability of benefiting from an alternative treatment, as suggested by this model. Consequently, we devised a two-stage test with optimized negative and positive predictive values as the main indicators of performance. Our analysis was based on 2,377 patients that underwent PCI. Performance was compared with a conventional classification model and the existing clinical practice by estimating effectiveness, safety, and costs for different endpoints (6 month angiographic restenosis, 12 and 36 month hazardous events). RESULTS: Compared to the current clinical practice, the proposed method achieved an estimated reduction in adverse effects by 25.0% (95% CI, 17.8 to 30.2) for hazardous events at 36 months and 31.2% (95% CI, 25.4 to 39.0) for hazardous events at 12 months. Estimated total savings per patient amounted to $693 and $794 at 12 and 36 months, respectively. The proposed subgroup-specific method outperformed conventional population wide regression: The median area under the receiver operating characteristic curve increased from 0.57 to 0.61 for prediction of angiographic restenosis and from 0.76 to 0.85 for prediction of hazardous events. CONCLUSIONS: The results of this study demonstrated the efficacy of deployment of bare-metal stents and coronary artery bypass grafting surgery for subsets of patients. This is one effort towards development of personalized treatment strategies for patients with coronary atherosclerosis that could significantly impact associated treatment costs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12911-015-0131-0) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-14 /pmc/articles/PMC4336731/ /pubmed/25889930 http://dx.doi.org/10.1186/s12911-015-0131-0 Text en © Pölsterl et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Pölsterl, Sebastian
Singh, Maneesh
Katouzian, Amin
Navab, Nassir
Kastrati, Adnan
Ladic, Lance
Kamen, Ali
Stratification of coronary artery disease patients for revascularization procedure based on estimating adverse effects
title Stratification of coronary artery disease patients for revascularization procedure based on estimating adverse effects
title_full Stratification of coronary artery disease patients for revascularization procedure based on estimating adverse effects
title_fullStr Stratification of coronary artery disease patients for revascularization procedure based on estimating adverse effects
title_full_unstemmed Stratification of coronary artery disease patients for revascularization procedure based on estimating adverse effects
title_short Stratification of coronary artery disease patients for revascularization procedure based on estimating adverse effects
title_sort stratification of coronary artery disease patients for revascularization procedure based on estimating adverse effects
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336731/
https://www.ncbi.nlm.nih.gov/pubmed/25889930
http://dx.doi.org/10.1186/s12911-015-0131-0
work_keys_str_mv AT polsterlsebastian stratificationofcoronaryarterydiseasepatientsforrevascularizationprocedurebasedonestimatingadverseeffects
AT singhmaneesh stratificationofcoronaryarterydiseasepatientsforrevascularizationprocedurebasedonestimatingadverseeffects
AT katouzianamin stratificationofcoronaryarterydiseasepatientsforrevascularizationprocedurebasedonestimatingadverseeffects
AT navabnassir stratificationofcoronaryarterydiseasepatientsforrevascularizationprocedurebasedonestimatingadverseeffects
AT kastratiadnan stratificationofcoronaryarterydiseasepatientsforrevascularizationprocedurebasedonestimatingadverseeffects
AT ladiclance stratificationofcoronaryarterydiseasepatientsforrevascularizationprocedurebasedonestimatingadverseeffects
AT kamenali stratificationofcoronaryarterydiseasepatientsforrevascularizationprocedurebasedonestimatingadverseeffects